"Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women"

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 21, 2019

Primary Completion Date

March 25, 2021

Study Completion Date

April 30, 2021

Conditions

Insulin Sensitivity

Interventions

DRUG

intranasal insulin

application of 160 units human insulin

DRUG

Placebo spray

nasal spray containing placebo solution

Trial Locations (1)

University of Tuebingen, Department of Internal Medicine IV, Tübingen

All Listed Sponsors

lead

University Hospital Tuebingen

OTHER

NCT03929419 - "Effect of Central Insulin Administration on Whole-body Insulin Sensitivity in Women" | Biotech Hunter | Biotech Hunter